Facebook Twitter
Print

S37: The Role of Integrative Oncology in Cancer Survivorship: State of the Science and Opportunities

15:00 - 16:30, Ashe Auditorium, Third Level

Jun Mao (1), Lorenzo Cohen (2), Heather Greenlee (3)

(1): Perelman School of Medicine at the University of Pennsylvania, United States

(2): University of Texas MD Anderson Cancer Center, United States

(3): Columbia University, New York, United States

 

 

As cancer affects individuals on physical, emotional, and spiritual levels, the majority of cancer survivors use complementary and integrative medicine (CIM) to regain a sense of control, address symptom burden, and improve outcomes. The National Cancer Institute (NCI) has the Office of Cancer Complementary and Alternative Medicine (OCCAM) and the National Institutes of Health (NIH) has a specific center focusing on CIM research (NCCAM). With the increased NIH funding for CIM research, rigorous research is being conducted to evaluate the mechanisms, efficacy, and integration of CIM to improve outcomes for individuals affected by cancer. There are also a number of societies that have formed with a focus on evidence-based integration of CAM into conventional cancer care settings, including the Society for Integrative Oncology (SIO) and the Consortium of Academic Health Centers for Complementary and Integrative Medicine (CAHCIM). However, even with the increase in high quality CIM research and formation of new societies, information about valuable CIM therapies and the integration of evidence-based treatments into the standard cancer care remains low. In an effort to increase dissemination of evidence-based CIM in the field of oncology, the SIO and the CAHCIM have jointly developed a special monograph to be published by the Journal of National Cancer Institute (JNCI) with the working title “The Role of Integrative Oncology in Cancer Survivorship”¬Ěto be released September 2014. This symposium will synthesize the state of science in integrative oncology based on articles and content from this special JNCI monograph. Guest editors and lead authors of the key papers will: 1) review current scientific gaps and opportunities in integrative oncology; 2) discuss methodological challenges and propose solutions to enhance the quality of integrative oncology research; and 3) present procedures and strategies to synthesize evidence, and summarize the latest SIO guidelines for integrative oncology clinical care.